Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

In situ detection of Androgen Receptor splice variants in prostate cancer cells

Project Leader:

El-Heliebi Amin

Duration:

01.01.2016-31.12.2016

Type of Research

applied research

Staff

El-Heliebi, Amin, Project Leader

MUG Research Units

Division of Cell Biology, Histology and Embryology

Funded by

Franz-Lanyar-Stiftung, Graz, Austria

Project results published

> Visualisation and quantification of AR-V7, AR-FL, ... International Symposium on Minimal Residual Cancer; MAY 3-5, 2018; Montpellier, FRANCE. 2018.

> Early detection of therapy resistance in prostate ... Nano World Cancer Day 2018 - Precision Medicine for People – Smart Biomarkers, Nanotechnologies and more; JAN 31, 2018; Vienna, AUSTRIA. 2018.

> Molecular biomarkers for cancer research using liq... International Biotech Innovation Days ; MAY 23-25, 2018; Senftenberg, GERMANY. 2018.

> Technological advances in the analysis of liquid b... Fraunhofer Institute for Cell Therapy and Immunology IZI; SEP 3-5, 2018; Potsdam, GERMANY. 2018.

> Using liquid biopsies to guide treatment decisions... Diagnostics-4-Future Conference 2018; NOV 28, 2018; Konstanz, Germany. 2018.

> An in situ padlock probe approach to detect Andro... CRUK CI Symposium: Applications of in-situ hybridisation in research and disease at Cancer Research UK Cambridge Institute ; MAY 17-18, 2017; Cambridge, United Kingdom. 2017.

> A liquid biopsy to detect Androgen Receptor Varian... EACR Conference on Cancer Genomics; JUN 25-28,2016; Cambridge, United Kingdom. 2017.